84
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Metabolic syndrome is associated with changes in D-mannose metabolism

, &
Pages 607-612 | Published online: 08 Jul 2009

REFERENCES

  • Jolley RL, Warren KS, Scott CD, Jainchill JL, Freeman ML. Carbohydrates in normal urine and blood serum as determined by high-resolution column chromatography. Am J Clin Pathol 1970; 53: 793–802.
  • Akazawa S, Metzger BE, Freinkel N. Relation-ships between glucose and mannose during late gestation in normal pregnancy and pregnancy complicated by diabetes mellitus: concurrent con-centrations in maternal plasma and amniotic fluid. J Clin Endocr Metab 1986; 62: 984–9.
  • Pitkänen E. Mannose, mannitol, fructose and 1,5-anhydroglucitol concentrations measured by gas chromatography/mass spectrometry in blood plasma of diabetic patients. Clin Chim Acta 1996; 251: 91–103.
  • Radhakrishnamurthy B, Berenson GS, Pargaon-kar PS, Voors AW, Srinivasan SR, Plavidal F, Dolan P, Dalferes ER. Serum-free and protein-bound sugars and cardiovascular compli-cations in diabetes mellitus. Lab Invest 1976; 34: 159— 65.
  • Pitkänen E. Proteinuria and plasma hexosugars in early-stage glomerulonephritis. Clin Nephrol 1996; 45: 226–9.
  • Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
  • The European Diabetes Epidemiology Group. Epidemiological considerations related to the new diagnostic criteria for diabetes mellitus Diabetologia 1998; 41: 51–2.
  • Ferrara LA, Marotta T. Nitrendipine and meta-bolic balance. J Cardiovasc Pharmacol 1991; 18 Suppl 5: S19–21.
  • Thurig C, Bohlen L, Schneider M, de Courten M, Shaw SG, Riesen W, Weidmann P. Lisinopril is neutral to insulin sensitivity and serum lipopro-teins in essential hypertensive patients. Eur J Clin Pharmacol 1995; 49: 21–6.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–50.
  • Pitkänen E, Pitkänen 0, Uotila L. Enzymatic determination of unbound D-mannose in serum. Eur J Clin Chem Clin Biochem 1997; 35: 761–6.
  • Hollmann S. Non-glycolytic pathways of metabo-lism of glucose. New York and London: Academic Press, 1964; 41–4.
  • Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeo-genesis in type II diabetes mellitus. J Clin Invest 1992; 90: 1323–7.
  • Randle PJ, Priestman DA, Mistry S, Halsall A. Mechanisms modifying glucose oxidation in dia-betes mellitus. Diabetologia 1994; 37 Suppl 2: S155 — 61.
  • Belfiore F, Romeo F, Iannello S, Salamone C. The glucose-6-phosphatase/glucokinase ratio in the liver of obese-diabetic subjects. Biochem Med Metal Biol 1989; 41: 77–80.
  • Proudfoot AE, Turcatti G, Wells TN, Payton MA, Smith DJ. Purification, cDNA cloning and heterologous expression of human phosphoman-nose isomerase. Eur J Biochem 1994; 219: 415–23.
  • Ortmeyer HK, Bodkin NL, Hansen BC. Relation-ship of skeletal muscle glucose-6-phosphate to glucose disposal rate and glycogen synthase activity in insulin-resistant and non-insulin-depen-dent diabetic rhesus monkeys. Diabetologia 1994; 37: 127–33.
  • Kissebah AH, Alfarsi S, Adams PW, Wynn V. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hyper-triglyceridaemia in man. Diabetologia 1976; 12: 563— 71.
  • Sparks JD, Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secre-tion. Biochim Biophys Acta 1994; 1215: 9–32.
  • Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, Thompson GR, Sönksen PH. Increased hepatic secretion of very-low-density lipoprotein apolipo-protein B-100 in NIDDM. Diabetologia 1995; 38: 959— 67.
  • McMillan DE. 1989 Increased levels of acute-phase proteins in diabetes. Metabolism 1995; 38: 1042 — 6.
  • Gill CW, Bush WS, Buleigh WM, Cooke-Gomes D. Elevation of IgA levels in the non-insulin-dependent (Type II) diabetic patient. Diabetes Care 1981; 4: 636–9.
  • Baxter JH, Goodman HC, Havel RJ. Serum lipid and lipoprotein alterations in nephrosis. J Clin Invest 1960; 39: 455–65.
  • Joven J, Villabona C, Masana L, Valles M. Increased low density lipoprotein synthesis in patients with nephrotic syndrome. Med Sci Res 1987; 15: 847–8.
  • Eckel RH. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989; 320: 1060— 8.
  • Björntorp P. Abdominal obesity and the develop-ment of noninsulin-dependent diabetes mellitus. Diab/Metab Rev 1988; 4: 615–22.
  • Tappy L. Regulation of hepatic glucose produc-tion in healthy subjects and patients with non-insulin-dependent diabetes mellitus. Diabete et Metabolisme 1995; 212: 233 — 40.
  • Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J. Relation between obesity from child-hood to adulthood and the metabolic syndrome: population based study. Br Med J 1998; 317: 319.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.